What is a telangiectasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Telangiectasia

A telangiectasia is a small dilated blood vessel (venule, capillary, or arteriole) that appears as a visible red-purple focal lesion on the skin or mucous membranes, measuring less than 1 mm in diameter. 1

Physical Characteristics

  • Telangiectasias appear as small red-purple focal lesions representing permanently dilated superficial blood vessels visible through the skin or mucous membrane surface 2
  • These lesions measure less than 1 mm in diameter when fully developed, distinguishing them from larger reticular veins (1-3 mm) and varicose veins (≥3 mm) 1
  • The vessels involved can be venules, capillaries, or arterioles, with thin walls that are prone to rupture and bleeding in certain conditions 3
  • Some telangiectasias may appear as red telangiectatic macules within a tan or brown background, particularly in rare variants like telangiectasia macularis eruptiva persistans 4

Clinical Distribution and Common Locations

  • Telangiectasias commonly develop on characteristic sites including the lips, oral cavity, tongue, hard palate, fingers, nose, and ears 3, 5
  • They occur in 43% of men and 55% of women as isolated findings (spider veins), representing a common benign condition 1
  • The location and distribution pattern, combined with careful history, often helps distinguish between benign isolated lesions and those indicating serious underlying disorders 6

Clinical Significance: When to Worry

Multiple telangiectasias at characteristic sites constitute one of the four Curaçao diagnostic criteria for Hereditary Hemorrhagic Telangiectasia (HHT), a potentially life-threatening autosomal dominant disorder. 3, 4

Red Flags Requiring Further Evaluation:

  • Recurrent spontaneous epistaxis (nosebleeds) combined with telangiectasias suggests HHT and requires immediate specialist referral 3, 5
  • Family history of recurrent nosebleeds or HHT in combination with visible telangiectasias warrants comprehensive screening for arteriovenous malformations 3, 5
  • Multiple telangiectasias appearing at characteristic sites (lips, oral mucosa, fingers, ears) should trigger application of Curaçao criteria 5
  • Telangiectasias appearing in childhood (typically by age 5) with progressive neurological deterioration may indicate Ataxia Telangiectasia 5

Critical Pitfall to Avoid:

Never dismiss isolated ear or facial telangiectasias without screening for HHT using Curaçao criteria, as this represents a potentially life-threatening condition with asymptomatic arteriovenous malformations that can cause stroke or cerebral abscess 5

Primary vs. Secondary Telangiectasias

Primary (Benign) Telangiectasias:

  • Occur spontaneously without underlying disease 6
  • Include common spider veins on legs and face 1
  • Primarily a cosmetic concern 7

Secondary Telangiectasias (Markers of Underlying Disease):

  • Post-radiation therapy: Develop in irradiated tissues, often appearing years after treatment, with risk determined by radiation dose 5
  • Prolonged topical steroid application: Result from chronic corticosteroid-induced skin changes 6
  • Sun damage: Chronic actinic damage causes vessel dilation 6
  • Hereditary Hemorrhagic Telangiectasia: Symptoms typically appear around age 30, with epistaxis starting at mean age 11 years 4
  • Systemic diseases: Can serve as cutaneous markers for serious internal conditions or malignancies 6, 2

When to Refer for Specialist Evaluation

Refer to an HHT specialist if ≥2 Curaçao criteria are present (epistaxis, multiple telangiectasias, visceral AVMs, or first-degree relative with HHT) for comprehensive organ screening including pulmonary, cerebral, and hepatic arteriovenous malformations 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Telangiectasias: Small lesions referring to serious disorders.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2017

Guideline

Diagnostic Approach for Hereditary Hemorrhagic Telangiectasia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Mucocutaneous Telangiectasia Characteristics and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Telangiectasia on the Back of the Ear

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A clinical approach to diagnose patients with localized telangiectasia.

International journal of dermatology, 2015

Research

Treatment of telangiectasia: a review.

Journal of the American Academy of Dermatology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.